Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 16

1.

Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.

Roehr B.

BMJ. 2012 Oct 2;345:e6633. doi: 10.1136/bmj.e6633. No abstract available.

PMID:
23033376
2.

The Physician Payments Sunshine Act and the unaddressed role of nurses: an interest group analysis.

Grundy Q.

Policy Polit Nurs Pract. 2012 Aug;13(3):154-61. doi: 10.1177/1527154412465196. Review.

PMID:
23416630
3.

Strains in the fiduciary metaphor: divided physician loyalties and obligations in a changing health care system.

Rodwin MA.

Am J Law Med. 1995;21(2-3):241-57. Review. No abstract available.

PMID:
8571977
4.

[Conflict of interest regarding clinical psychiatrist' relationship with global pharmaceutical industries].

Eguchi S.

Seishin Shinkeigaku Zasshi. 2010;112(11):1117-23. Review. Japanese. No abstract available.

PMID:
21351691
5.

Professionalism and physician interactions with industry.

Collins J.

J Am Coll Radiol. 2006 May;3(5):325-32. Review.

PMID:
17412075
6.

[Conflict of interest viewed from over-sea reports regarding relationship between clinical psychiatry and drug industry].

Senba J.

Seishin Shinkeigaku Zasshi. 2010;112(11):1124-9. Review. Japanese. No abstract available.

PMID:
21351692
7.

Medical commerce, physician entrepreneurialism, and conflicts of interest.

Rodwin MA.

Camb Q Healthc Ethics. 2007 Fall;16(4):387-97; discussion 439-42. Review. No abstract available.

PMID:
18018918
8.

Conflict of interest in online point-of-care clinical support websites.

Amber KT, Dhiman G, Goodman KW.

J Med Ethics. 2014 Aug;40(8):578-80. doi: 10.1136/medethics-2013-101625. Epub 2014 Feb 3. Review.

PMID:
24493079
9.

Use of antipsychotic medications in pediatric populations: what do the data say?

Penfold RB, Stewart C, Hunkeler EM, Madden JM, Cummings JR, Owen-Smith AA, Rossom RC, Lu CY, Lynch FL, Waitzfelder BE, Coleman KJ, Ahmedani BK, Beck AL, Zeber JE, Simon GE.

Curr Psychiatry Rep. 2013 Dec;15(12):426. doi: 10.1007/s11920-013-0426-8. Review. Erratum in: Curr Psychiatry Rep. 2014 Feb;16(2):432. Coleman, Karen A [corrected to Coleman, Karen J].

10.

Spin your science into gold: direct to consumer marketing within social media platforms.

Egilman D, Druar NM.

Work. 2012;41 Suppl 1:4494-502. doi: 10.3233/WOR-2012-0751-4494. Review.

PMID:
22317414
11.

Patients can't trust doctors' advice if we hide our financial connections with drug companies.

Wen L.

BMJ. 2014 Jan 15;348:g167. doi: 10.1136/bmj.g167. Review. No abstract available.

PMID:
24430529
12.

[Physician versus 'off-label" ordinance].

Kordus K, Spiewak R.

Przegl Lek. 2015;72(1):38-41. Review. Polish.

PMID:
26076577
13.

["Off label" use of some medicinal products. Part I].

Sirakov M.

Akush Ginekol (Sofiia). 2012;51(2):29-32. Review. Bulgarian.

PMID:
23234011
15.

Soft targets: nurses and the pharmaceutical industry.

Jutel A, Menkes DB.

PLoS Med. 2008 Feb;5(2):e5. doi: 10.1371/journal.pmed.0050005. Review. No abstract available.

16.

The complexity of covering off-label use for a multitude of oncology regimens.

Mehr SR.

Am J Manag Care. 2012 Dec;18(5 Spec No.):SP242-7. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk